57 related articles for article (PubMed ID: 12747769)
1. ELISPOT cloning of tumor antigens recognized by cytotoxic T-lymphocytes from a cDNA expression library.
Uenaka A; Hata H; Win S; Ono T; Wada H; Nakayama E
Cancer Immun; 2001 Jul; 1():8. PubMed ID: 12747769
[TBL] [Abstract][Full Text] [Related]
2. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5' region of the c-akt proto-oncogene activated by long terminal repeat.
Wada H; Matsuo M; Uenaka A; Shimbara N; Shimizu K; Nakayama E
Cancer Res; 1995 Nov; 55(21):4780-3. PubMed ID: 7585504
[TBL] [Abstract][Full Text] [Related]
3. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
[TBL] [Abstract][Full Text] [Related]
4. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
5. Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).
Uenaka A; Nakayama E
Cancer Sci; 2003 Nov; 94(11):931-6. PubMed ID: 14611667
[TBL] [Abstract][Full Text] [Related]
6. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
7. Identification of a CD4 T-cell epitope in tumor rejection antigen RLakt on BALB/c radiation-leukemia RL male 1.
Kaya S; Uenaka A; Sato S; Ono T; Aji T; Nakayama E
Cancer Sci; 2008 Jul; 99(7):1441-7. PubMed ID: 18452555
[TBL] [Abstract][Full Text] [Related]
8. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene.
Uenaka A; Ono T; Akisawa T; Wada H; Yasuda T; Nakayama E
J Exp Med; 1994 Nov; 180(5):1599-607. PubMed ID: 7964448
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.
De Plaen E; Lurquin C; Lethé B; van der Bruggen P; Brichard V; Renauld JC; Coulie P; Van Pel A; Boon T
Methods; 1997 Jun; 12(2):125-42. PubMed ID: 9184377
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
11. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
12. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
13. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptide.
Palena C; Schlom J; Tsang KY
Clin Cancer Res; 2003 May; 9(5):1616-27. PubMed ID: 12738714
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T-lymphocytes and the GM-CSF gene by in vivo electroporation.
Tanaka M; Yamada M; Ono T; Noguchi Y; Uenaka A; Ota S; Hata H; Harada M; Tanimoto M; Nakayama E
Cancer Sci; 2004 Feb; 95(2):154-9. PubMed ID: 14965366
[TBL] [Abstract][Full Text] [Related]
16. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
17. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
[TBL] [Abstract][Full Text] [Related]
18. [Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma].
Zeng B; Lu FG; Liu XW; Yang DY; Fang WY; Wang J; Liao AJ; Shi W
Ai Zheng; 2005 Nov; 24(11):1332-7. PubMed ID: 16552958
[TBL] [Abstract][Full Text] [Related]
19. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
[TBL] [Abstract][Full Text] [Related]
20. Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma.
Onishi H; Morisaki T; Baba E; Nakamura M; Inaba S; Kuroki H; Matsumoto K; Katano M
Anticancer Res; 2011 Nov; 31(11):3995-4005. PubMed ID: 22110233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]